JP2008523140A5 - - Google Patents

Download PDF

Info

Publication number
JP2008523140A5
JP2008523140A5 JP2007546603A JP2007546603A JP2008523140A5 JP 2008523140 A5 JP2008523140 A5 JP 2008523140A5 JP 2007546603 A JP2007546603 A JP 2007546603A JP 2007546603 A JP2007546603 A JP 2007546603A JP 2008523140 A5 JP2008523140 A5 JP 2008523140A5
Authority
JP
Japan
Prior art keywords
separation matrix
matrix according
particles
binding protein
ligand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007546603A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008523140A (ja
JP5787461B2 (ja
Filing date
Publication date
Priority claimed from SE0403057A external-priority patent/SE0403057D0/sv
Application filed filed Critical
Priority claimed from PCT/SE2005/001900 external-priority patent/WO2006065208A1/en
Publication of JP2008523140A publication Critical patent/JP2008523140A/ja
Publication of JP2008523140A5 publication Critical patent/JP2008523140A5/ja
Application granted granted Critical
Publication of JP5787461B2 publication Critical patent/JP5787461B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007546603A 2004-12-14 2005-12-12 免疫グロブリンの精製方法 Expired - Lifetime JP5787461B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE0403057-3 2004-12-14
SE0403057A SE0403057D0 (sv) 2004-12-14 2004-12-14 Purification of immunoglobulins
US63831604P 2004-12-22 2004-12-22
US60/638,316 2004-12-22
PCT/SE2005/001900 WO2006065208A1 (en) 2004-12-14 2005-12-12 Purification of immunoglobulins

Publications (3)

Publication Number Publication Date
JP2008523140A JP2008523140A (ja) 2008-07-03
JP2008523140A5 true JP2008523140A5 (https=) 2008-12-11
JP5787461B2 JP5787461B2 (ja) 2015-09-30

Family

ID=36588164

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007546603A Expired - Lifetime JP5787461B2 (ja) 2004-12-14 2005-12-12 免疫グロブリンの精製方法

Country Status (5)

Country Link
EP (1) EP1830947A4 (https=)
JP (1) JP5787461B2 (https=)
AU (1) AU2005317279C1 (https=)
CA (1) CA2586803C (https=)
WO (1) WO2006065208A1 (https=)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006232287B2 (en) 2005-03-31 2011-10-06 Chugai Seiyaku Kabushiki Kaisha Methods for producing polypeptides by regulating polypeptide association
EP2009101B1 (en) 2006-03-31 2017-10-25 Chugai Seiyaku Kabushiki Kaisha Antibody modification method for purifying bispecific antibody
CN104761637B (zh) 2006-03-31 2021-10-15 中外制药株式会社 调控抗体血液动力学的方法
WO2008039141A1 (en) 2006-09-29 2008-04-03 Ge Healthcare Bio-Sciences Ab Chromatography ligand comprising domain c from staphyloccocus aureus protein a for antibody isolation
SG149759A1 (en) * 2007-07-10 2009-02-27 Millipore Corp Media for affinity chromatography
ES2595638T3 (es) 2007-09-26 2017-01-02 Chugai Seiyaku Kabushiki Kaisha Método para modificar el punto isoeléctrico de un anticuerpo mediante la sustitución de aminoácidos en una CDR
KR101680906B1 (ko) 2007-09-26 2016-11-30 추가이 세이야쿠 가부시키가이샤 항체 정상영역 개변체
US8277649B2 (en) * 2009-12-14 2012-10-02 General Electric Company Membranes and associated methods for purification of antibodies
WO2011108714A1 (ja) 2010-03-04 2011-09-09 中外製薬株式会社 抗体定常領域改変体
CA2791918C (en) * 2010-03-05 2019-11-19 Boehringer Ingelheim International Gmbh Selective enrichment of antibodies
US8859294B2 (en) 2010-03-17 2014-10-14 Panasonic Corporation Method for binding a protein consisting of protein A or consisting of at least one domain of the A to E domains of the protein A to the substrate
JP4987165B2 (ja) * 2010-03-17 2012-07-25 パナソニック株式会社 プロテインａ、またはプロテインａのａ〜ｅドメインの少なくとも１つからなるタンパク質を基板の表面に結合させる方法
KR102006097B1 (ko) 2010-03-31 2019-07-31 제이에스알 가부시끼가이샤 친화성 크로마토그래피용 충전제
US9162161B2 (en) 2010-03-31 2015-10-20 Jsr Corporation Filler for affinity chromatography
TWI452136B (zh) 2010-11-17 2014-09-11 中外製藥股份有限公司 A multiple specific antigen-binding molecule that replaces the function of Factor VIII in blood coagulation
PT3434767T (pt) 2010-11-30 2026-01-23 Chugai Pharmaceutical Co Ltd Agente terapêutico indutor de citotoxicidade
CN105518023A (zh) 2013-08-30 2016-04-20 株式会社钟化 Fab区域结合性肽
EP3042192A4 (en) * 2013-09-04 2017-04-26 Sten Ohlson Weak affinity chromatography
JP6230853B2 (ja) * 2013-09-06 2017-11-15 株式会社日立製作所 タンパク質の精製方法及び精製装置
ES2881306T3 (es) 2013-09-27 2021-11-29 Chugai Pharmaceutical Co Ltd Método para la producción de heteromultímeros de polipéptidos
KR101921392B1 (ko) 2013-11-27 2018-11-22 제이에스알 가부시끼가이샤 고상 담체, 고상 담체의 제조 방법, 친화성 정제용 담체, 친화성 크로마토그래피용 충전제의 제조 방법, 친화성 크로마토그래피용 충전제, 크로마토그래피 칼럼 및 정제 방법
EP3094391B1 (en) 2014-01-17 2024-11-20 Repligen Corporation Sterilizing chromatography columns
WO2015197338A1 (en) 2014-06-24 2015-12-30 Ge Healthcare Bio-Sciences Ab Chromatography method
EP3162809B1 (en) 2014-06-27 2021-08-04 JSR Corporation Carrier for affinity chromatography
US20170334947A1 (en) * 2014-08-28 2017-11-23 Kaneka Corporation Affinity separation matrix for fab region-containing peptide
WO2016121701A1 (ja) 2015-01-26 2016-08-04 株式会社カネカ 免疫グロブリンκ鎖可変領域含有タンパク質精製用アフィニティー分離マトリックス
CN108064286A (zh) 2015-01-26 2018-05-22 株式会社钟化 突变型免疫球蛋白κ链可变区结合性肽
JP7082484B2 (ja) 2015-04-01 2022-06-08 中外製薬株式会社 ポリペプチド異種多量体の製造方法
AU2016381992B2 (en) * 2015-12-28 2024-01-04 Chugai Seiyaku Kabushiki Kaisha Method for promoting efficiency of purification of Fc region-containing polypeptide
CR20180554A (es) 2016-04-28 2019-01-10 Chugai Pharmaceutical Co Ltd Preparaciones que contienen anticuerpos
WO2017195638A1 (ja) 2016-05-09 2017-11-16 株式会社カネカ 抗体またはκ鎖可変領域含有抗体断片の精製方法
WO2017195641A1 (ja) * 2016-05-11 2017-11-16 株式会社カネカ アフィニティ分離マトリックスの製造方法およびアフィニティ分離マトリックス
GB201703116D0 (en) * 2017-02-27 2017-04-12 Ge Healthcare Bioprocess R&D Ab A seperation matrix and a method of seperating antibodies
CN110461358A (zh) 2017-03-31 2019-11-15 公立大学法人奈良县立医科大学 可用于预防和/或治疗凝血因子ⅸ异常、包含代替凝血因子ⅷ的功能的多特异性抗原结合分子的药物组合物
CN119161488A (zh) 2017-11-01 2024-12-20 中外制药株式会社 具有降低的生物活性的抗体变体和同种型

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
US5089605A (en) * 1987-03-13 1992-02-18 Repligen Corporation Immobilized immunoglobulin-binding proteins
US5445732A (en) * 1992-06-19 1995-08-29 Sepracor Inc. Passivated porous polymer supports and methods for the preparation and use of same
CA2158056A1 (en) * 1993-03-29 1994-10-13 William H. Velander Method of coupling ligands within porous supports (p.e. azlactone) and uses thereof
SE9503925D0 (sv) * 1995-11-07 1995-11-07 Pharmacia Biotech Ab Separationsmedium för IgG
SE9601368D0 (sv) * 1996-04-11 1996-04-11 Pharmacia Biotech Ab Process for the production of a porous cross-linked polysaccharide gel
EP1693402A3 (en) * 1997-01-07 2009-05-27 Kaneka Corporation Cellulosic particles, spherical object comprising cross-linked polymer particles, and adsorbent for body fluid purification
SE9700383D0 (sv) * 1997-02-04 1997-02-04 Pharmacia Biotech Ab An adsorption/separation method and a medium for adsorption/separation
SE0004929D0 (sv) * 2000-12-29 2000-12-29 Apbiotech Ab A method for producing liquid chromatography matrices
SE0200943D0 (sv) * 2002-03-25 2002-03-25 Amersham Biosciences Ab Mutant protein
SE0300482D0 (sv) * 2003-02-21 2003-02-21 Amersham Biosciences Ab Inorganic beads with hierarchical pore structures
US7700743B2 (en) * 2003-07-22 2010-04-20 Millipore Corporation Immobilised affinity medium and its use in separation
CA2581208A1 (en) * 2004-08-30 2006-03-09 Lonza Biologics Plc. Affinity- plus ion exchange- chromatography for purifying antibodies

Similar Documents

Publication Publication Date Title
JP2008523140A5 (https=)
Kumar et al. Affinity fractionation of lymphocytes using a monolithic cryogel
Saylan et al. Supermacroporous composite cryogels in biomedical applications
Völlenkle et al. Construction of a functional S-layer fusion protein comprising an immunoglobulin G-binding domain for development of specific adsorbents for extracorporeal blood purification
Purtov et al. Nanodiamonds as carriers for address delivery of biologically active substances
WO2006066598A3 (en) Antibody binding affinity ligands
Gooding et al. Hplc of biological macro-molecules, revised and expanded
Salimi et al. Protein A and protein A/G coupled magnetic SiO2 microspheres for affinity purification of immunoglobulin G
Vallhov et al. Dendritic cell‐derived exosomes carry the major cat allergen F el d 1 and induce an allergic immune response
BRPI0606375A2 (pt) método de produzir um sistema catalisador heterogêneo, sistema catalisador, e, método de catálise
JP2013507237A5 (https=)
Caurie Hysteresis phenomenon in foods
Chen et al. High performance of a unique mesoporous polystyrene-based adsorbent for blood purification
JP2002531090A5 (https=)
Eggermont et al. Cytokine‐functionalized synthetic dendritic cells for T cell targeted immunotherapies
Mhemeed A general overview on the adsorption
JP2010534336A5 (https=)
JPS60501209A (ja) 生物学的活性物質の精製方法
Xu et al. Feasibility of using DNA-immobilized nanocellulose-based immunoadsorbent for systemic lupus erythematosus plasmapheresis
Akkaya et al. Concanavalin A immobilized magnetic poly (glycidyl methacrylate) beads for antibody purification
Ettenauer et al. Characterization and functionalization of cellulose microbeads for extracorporeal blood purification
Soares et al. Molecular imprinting of β-cyclodextrin/cholesterol template into a silica polymer for cholesterol separation
Weber et al. Development of affinity microparticles for extracorporeal blood purification based on crystalline bacterial cell surface proteins
JP2014512367A5 (https=)
Thipe et al. Hybrid nanomaterials for detection, detoxification, and management mycotoxins